Discovery
Medicinal Chemistry Services
Discovery ADME
- Metabolic Stability
- CYP Interaction
- Permeability & Transporters
- Physicochemical Properties
- Protein Binding
›
›
›
›
›
›
›
white-paper
Decades of studies have conclusively demonstrated that smoking combustible cigarettes, as well as second-hand smoke, are major causes of global morbidity and mortality from a constellation of conditions, including but not limited to chronic disorders such as pulmonary and cardiovascular disease, and multiple types of cancer. The most effective approach to harm reduction is smoking cessation. However, the addictive nature of nicotine and the behavioral aspects of smoking make this a challenging process. There is therefore a significant need to develop and regulate products such as e-cigarettes, that could potentially serve as reduced-risk alternatives. In this paper, we provide background on clinical studies in the US for new tobacco products and delineate how the appropriate testing facilities, equipment, and experienced staff are essential to generating high-quality data.
Register to gain access to gated resources.
Thank you for registering!
You now have the option of downloading the resource or viewing the web version below.
Frontage Laboratories websites use cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details about cookies, and their use, please see our privacy policy.
Accept Privacy Policy